Come up with a name for your new list and we'll add to it:
Laurent Pharmaceuticals raised a round of funding on March 14, 2018. Investors include
Cystic Fibrosis Foundation.
Laurent Pharmaceuticals is a Canada-based clinical stage company focusing on rare inflammatory diseases. Laurent's lead drug candidate, LAU-7b, is a Phase 2 ready oral drug addressing the compromised …